https://www.creative-biolabs.com/bsab/bispecific-ad-fiber-knob-cd40-igg-l-scfv-10530.htm
Recombinant Anti-Ad fiber knob x Anti-CD40 Bispecific Antibody (IgG(L)-scFv) (IGLFV-002) - Creative...
Creative Biolabs can provide Recombinant Anti-Ad fiber knob x Anti-CD40 Bispecific Antibody (IgG(L)-scFv)
bispecific antibodyrecombinantadfiberknob
https://www.biospace.com/immunomedics-inc-reports-first-clinical-experience-with-new-generation-of-bispecific-antibody
Immunomedics, Inc. Reports First Clinical Experience With New Generation of Bispecific Antibody -...
clinical experiencenew generationbispecific antibodyimmunomedicsinc
https://ascopost.com/news/september-2021/bispecific-antibody-epcoritamab-in-relapsed-or-refractory-b-cell-non-hodgkin-lymphoma/
Bispecific Antibody Epcoritamab in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma - The ASCO...
In a phase I/II study reported in The Lancet, Hutchings et al found that the novel bispecific antibody epcoritamab produced high response rates in patients...
non hodgkin lymphomabispecific antibodyrefractorycellasco
https://virginiacancerspecialists.com/dictionary/bispecific-antibody-4g7xh22/
bispecific antibody 4G7xH22 - Virginia Cancer Specialists
A bispecific antibody containing a 4G7 hybridoma secreting IgG1 antibody specific for B-lymphocytes and a monoclonal antibody targeting Fc gamma
bispecific antibodycancer specialistsvirginia
https://blogs.shu.edu/cancer/tag/bispecific-antibody/
bispecific antibody | Cancer Biology
bispecific antibodycancer biology
https://www.ophthalmologymanagement.com/news/2026/ollin-biosciences-reports-positive-results-for-vegf-ang2-bispecific-antibody/
Ollin Biosciences Reports Positive Results for VEGF Ang2 Bispecific Antibody | Ophthalmology...
Jan 8, 2026 - Conexiant Vision: Delivering trusted clinical content, deep audience engagement, and educational resources for eye care professionals. Discover more through...
positive resultsbispecific antibodyollinbiosciencesreports
https://pharmashots.com/tag/bispecific-antibody-drug-conjugate/
bispecific antibody drug conjugate Archives - PharmaShots
Illuminate.Innovate.Inspire
bispecific antibodydrugconjugatearchives
https://jobs.future.ventures/companies/prellis-biologics/jobs/59771343-senior-scientist-bispecific-antibody-purification
Scientist/Senior Scientist - Bispecific Antibody Purification @ Prellis Biologics | Future Ventures...
Search job openings across the Future Ventures network.
bispecific antibodyscientistseniorpurificationbiologics
https://marketintelo.com/report/bispecific-antibody-oncology-therapeutics-market
Bispecific Antibody Oncology Therapeutics Market Research Report 2034
May 17, 2026 - The bispecific antibody oncology therapeutics market was valued at $11.4 billion in 2025 and is projected to reach $75.2 billion by 2034, growing at 23.8% CAGR.
market research reportbispecific antibodyoncologytherapeutics
https://pubmed.ncbi.nlm.nih.gov/39123089/
Preclinical development of a novel CCR8/CTLA-4 bispecific antibody for cancer treatment by...
Anti-CTLA-4 antibodies faced challenges due to frequent adverse events and limited efficacy, which spurred the exploration of next-generation CTLA-4...
for cancer treatmentpreclinical developmentbispecific antibodynovel
https://biopharmaapac.com/news/33/1649/harbour-biomed-announces-ind-approval-for-b7h4x4-1bb-bispecific-antibody.html
Harbour BioMed Announces IND Approval for B7H4x4-1BB Bispecific Antibody
Harbour BioMed Announces IND Approval for B7H4x4-1BB Bispecific Antibody
bispecific antibodyharbourbiomedannouncesind
https://www.zymeworks.com/publications/zw171-a-differentiated-21-t-cell-engaging-bispecific-antibody-with-antitumor-activity-in-a-range-of-mesothelin-expressing-cancers/
ZW171, a differentiated 2+1 T cell-engaging bispecific antibody with antitumor activity in a range...
Jan 6, 2026 - ZW171, a differentiated 2+1 T cell-engaging bispecific antibody with antitumor activity in a range of mesothelin-expressing cancers
bispecific antibodycellengagingactivityrange
https://www.sungenbiomed.com/
Sungen: Bispecific Antibody, Bispecific Antibody Companies
bispecific antibodycompanies
https://themmrf.org/hcp_resources/podcast/
Podcast: Bispecific Antibody Horizons: Dosing Strategies and Meeting Updates in Myeloma Care...
bispecific antibodymeeting updatespodcasthorizonsdosing
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd30-cd3-bispecific-antibody-gen3017
Definition of anti-CD30/CD3 bispecific antibody GEN3017 - NCI Drug Dictionary - NCI
Find technical definitions and synonyms by letter for drugs/agents used to treat patients with cancer or conditions related to cancer. Each entry includes...
bispecific antibodydrug dictionarydefinitionnci
https://ecancer.org/en/news/21390-ash-2021-bispecific-antibody-shows-75-response-rate-at-highest-dose-levels-in-heavily-pretreated-multiple-myeloma
ASH 2021: Bispecific antibody shows 75% response rate at highest dose levels in heavily pretreated...
New results for higher dose level cohorts of the investigational study REGN5458 (BCMAxCD3) bispecific antibody, which were presented in an oral session at the 2
bispecific antibodyresponse rateashshowshighest
https://pure.prinsesmaximacentrum.nl/en/publications/heterodimeric-complex-formation-with-cd8-and-tcr-by-bispecific-an/fingerprints/
Heterodimeric complex formation with CD8 and TCR by bispecific antibody sustains paracrine...
bispecific antibodycomplexformationtcrparacrine
https://blog.dana-farber.org/insight/2024/03/bispecific-antibody-therapy-for-lymphoma-what-you-need-to-know/
Bispecific Antibody Therapy for Lymphoma: What You Need to Know | Dana-Farber Cancer Institute
Mar 14, 2024 - Bispecific antibody therapies are a type of immunotherapy for patients with B-cell non-Hodgkin lymphoma.
what you needbispecific antibodycancer institutetherapylymphoma
https://ubccpd.ca/bispecific-antibody-therapy-cancer-care-what-acute-care-physicians-need-know-safe-administration
Bispecific Antibody Therapy in Cancer Care: What Acute Care Physicians Need to Know for Safe...
need to knowbispecific antibodyin cancertherapycare
https://www.cancer.columbia.edu/cancer-types-care/clinical-trials/find-clinical-trial/phase-1-study-jnj-87189401-psma-cd28-bispecific-antibody-combined-jnj-78278343-klk2-cd3-bispecific-antibody-advanced-prostate-cancer
A Phase 1 Study of JNJ-87189401 (PSMA-CD28 Bispecific Antibody) Combined with JNJ 78278343...
May 25, 2025 - The purpose of this study is to find out the side effects of JNJ-87189401 given in combination with JNJ-78278343 to patients with metastatic...
bispecific antibodyphasestudyjnjpsma
https://www.oncotarget.com/article/17558/text/
Structural basis of a novel heterodimeric Fc for bispecific antibody production | Oncotarget
https://doi.org/10.18632/oncotarget.17558 Hudie Wei, Haiyan Cai, Yuhao Jin, Pilin Wang, Qingqing Zhang, Yihui Lin, Weixiao Wang, Jinke Cheng, Naiyan Zeng, Ting...
a novelbispecific antibodystructuralbasisfc
https://www.creativebiolabs.net/bispecific-antibody-fagments-bsab-fragments.htm
Bispecific Antibody Fragment Generation Services - Creative Biolabs
Creative Biolabs provides diverse BsAb fragments with high affinity and low immunogenicity
bispecific antibodyservices creativefragmentgeneration
https://research.jku.at/en/activities/bispecific-antibody-activity-against-senescent-lymphoma-cells-2/
Bispecific antibody activity against senescent lymphoma cells - JKU & KUK Research Portal
bispecific antibodyresearch portalactivitylymphomacells
https://www.cellandgene.com/doc/face-the-unknown-key-bispecific-antibody-discoveries-0001
Face The Unknown Key Bispecific Antibody Discoveries
Bispecific antibodies (BsAbs) are revolutionizing biopharmaceuticals with enhanced therapeutic potential. Learn how advanced design tools and expert support...
the unknownbispecific antibodyfacekeydiscoveries
https://deceraclinical.com/education/events/bsab-mm-eha-2026/bsab-mm-eha-2026/26714-47354
Advances in Bispecific Antibody Therapy for Multiple Myeloma: Strategies to Personalize Treatment...
Join us in person or online for this interactive symposium in conjunction with EHA 2026, in which an expert panel of hematologic oncologists will discuss the...
bispecific antibodymultiple myelomaadvancestherapystrategies
https://www.jnj.com/media-center/press-releases/janssen-presents-updated-results-evaluating-first-in-class-gprc5d-bispecific-antibody-talquetamab-in-heavily-pretreated-patients-with-multiple-myeloma
Janssen Presents Updated Results Evaluating First-in-Class GPRC5D Bispecific Antibody Talquetamab...
Jul 18, 2025 - Updated results for talquetamab monotherapy and in combination with daratumumab highlighted in oral presentations at the 2022 EHA Annual Congress
first in classupdated resultsbispecific antibodyjanssenpresents
https://www.dynamic-biosensors.com/project/kinetic-analysis-of-ternary-and-binary-binding-modes-of-the-bispecific-antibody-emicizumab/
Kinetic analysis of ternary and binary binding modes of the bispecific antibody emicizumab -...
bispecific antibodykineticanalysisternarybinary
https://scholars.duke.edu/publication/1503381
Scholars@Duke publication: A phase 1 dose-escalation study of a PD-L1xCD27 bispecific antibody...
dose escalationbispecific antibodyscholarsdukepublication
https://www.talk.bio/2025/08/minghui-raises-131m-to-advance-pd.html
Minghui Raises $131M to Advance PD-1xVEGF Bispecific Antibody Program
bispecific antibodyadvancepdprogram